United States Tuberculosis Testing and Diagnostics Market was valued at USD 1.23 Billion in 2022 and is projected to reach USD 1.80 Billion by 2030, growing at a CAGR of 4.6% from 2024 to 2030.
The US Tuberculosis Testing and Diagnostics Market is witnessing significant growth due to the increasing demand for accurate, quick, and reliable testing methods. As the prevalence of tuberculosis (TB) remains a global concern, industries, especially healthcare providers, are relying heavily on advanced diagnostics solutions to manage and control the spread of the disease. The market is driven by innovations in testing technology, as well as the urgent need for early diagnosis and treatment to reduce the economic and health impacts of TB.
In the healthcare industry, the requirement for tuberculosis testing and diagnostics has evolved beyond just medical need. Hospitals, clinics, and government organizations require high-quality, affordable TB testing solutions to cater to their vast patient populations. Technologies such as PCR (Polymerase Chain Reaction), X-ray, and rapid molecular diagnostics are playing a crucial role in diagnosing TB at earlier stages. These solutions ensure faster, more accurate results, which is vital for effective treatment and control of the disease.
The increasing incidence of drug-resistant tuberculosis (DR-TB) in the US further accentuates the need for improved diagnostics. Industries, including pharmaceutical companies and healthcare facilities, are working closely to develop more sophisticated diagnostic tools. Rapid diagnostic tests and portable testing equipment are now in high demand, as they provide the ability to test patients in real-time, especially in remote areas or underserved communities. This facilitates faster interventions and better outcomes for TB patients.
The US market also shows a growing interest in automated systems that streamline the testing process, reduce human error, and enhance efficiency in laboratories. Moreover, the demand for non-invasive diagnostic methods is increasing, with more industries exploring the use of breath tests and other novel diagnostic techniques.
As the market continues to evolve, industries are focused on addressing the challenges of affordability and accessibility. Investment in research and development is crucial for driving the growth of the Tuberculosis Testing and Diagnostics Market in the US. With continued advancements in testing technologies, the future holds significant promise for more effective TB detection and control, benefiting both public health and the healthcare industry as a whole.
Get an In-Depth Research Analysis of the US Tuberculosis Testing and Diagnostics Market Size And Forecast [2025-2032]
Â
Roche
Thermo Fischer Scientific
Becton Dickinson
Abbott
Hologic
Qiagen
Sanofi
Oxford Immunotec
BioMerieux
Par Sterile
Bio-Rad Laboratories
Akonni Biosystems
Cepheid
Siemens Healthineer
Hain Lifescience
Epistem
Creative Diagnostics
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Tuberculosis Testing and Diagnostics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Tuberculosis Testing and Diagnostics Market
Laboratory-Based Tests
Point-of-Care Tests
Molecular Tests
Immunologic Tests
Culturing Techniques
Polymerase Chain Reaction (PCR)
Enzyme-Linked Immunosorbent Assay (ELISA)
Nucleic Acid Amplification Tests (NAATs)
Chest X-ray
Interferon Gamma Release Assays (IGRAs)
Hospitals
Diagnostic Laboratories
Research and Academic Institutions
Public Health Organizations
Home Care Settings
Sputum Samples
Blood Samples
BAL (Broncho-Alveolar Lavage) Samples
Urine Samples
Other Specimens
Latent Tuberculosis Infection (LTBI)
Active Tuberculosis Disease
Drug-Resistant Tuberculosis
Co-infection with HIV
Other Complications
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Tuberculosis Testing and Diagnostics Market Research Analysis
1. Introduction of the US Tuberculosis Testing and Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Tuberculosis Testing and Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Tuberculosis Testing and Diagnostics Market, By Type
6. US Tuberculosis Testing and Diagnostics Market, By Application
7. US Tuberculosis Testing and Diagnostics Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Tuberculosis Testing and Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/